Replimune Group Statistics
Total Valuation
Replimune Group has a market cap or net worth of $990.36 million. The enterprise value is $843.55 million.
| Market Cap | 990.36M |
| Enterprise Value | 843.55M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Replimune Group has 83.96 million shares outstanding. The number of shares has increased by 15.19% in one year.
| Current Share Class | 83.96M |
| Shares Outstanding | 83.96M |
| Shares Change (YoY) | +15.19% |
| Shares Change (QoQ) | +3.69% |
| Owned by Insiders (%) | 1.94% |
| Owned by Institutions (%) | 67.66% |
| Float | 59.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 30.13 |
| PB Ratio | 5.93 |
| P/TBV Ratio | 6.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.79, with a Debt / Equity ratio of 0.67.
| Current Ratio | 4.79 |
| Quick Ratio | 4.65 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.11 |
Financial Efficiency
Return on equity (ROE) is -107.88% and return on invested capital (ROIC) is -51.69%.
| Return on Equity (ROE) | -107.88% |
| Return on Assets (ROA) | -45.03% |
| Return on Invested Capital (ROIC) | -51.69% |
| Return on Capital Employed (ROCE) | -116.69% |
| Weighted Average Cost of Capital (WACC) | 8.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$675,140 |
| Employee Count | 465 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -551,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.06% in the last 52 weeks. The beta is 0.90, so Replimune Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +108.06% |
| 50-Day Moving Average | 9.66 |
| 200-Day Moving Average | 7.93 |
| Relative Strength Index (RSI) | 59.00 |
| Average Volume (20 Days) | 7,027,022 |
Short Selling Information
The latest short interest is 23.65 million, so 28.17% of the outstanding shares have been sold short.
| Short Interest | 23.65M |
| Short Previous Month | 23.67M |
| Short % of Shares Out | 28.17% |
| Short % of Float | 39.62% |
| Short Ratio (days to cover) | 7.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -318.32M |
| Pretax Income | -314.49M |
| Net Income | -313.94M |
| EBITDA | -313.39M |
| EBIT | -319.92M |
| Earnings Per Share (EPS) | -$3.38 |
Balance Sheet
The company has $268.89 million in cash and $111.59 million in debt, with a net cash position of $157.30 million or $1.87 per share.
| Cash & Cash Equivalents | 268.89M |
| Total Debt | 111.59M |
| Net Cash | 157.30M |
| Net Cash Per Share | $1.87 |
| Equity (Book Value) | 166.16M |
| Book Value Per Share | 2.01 |
| Working Capital | 220.89M |
Cash Flow
In the last 12 months, operating cash flow was -$280.34 million and capital expenditures -$4.22 million, giving a free cash flow of -$284.57 million.
| Operating Cash Flow | -280.34M |
| Capital Expenditures | -4.22M |
| Depreciation & Amortization | 5.76M |
| Net Borrowing | 34.26M |
| Free Cash Flow | -284.57M |
| FCF Per Share | -$3.39 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Replimune Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.19% |
| Shareholder Yield | -15.19% |
| Earnings Yield | -31.37% |
| FCF Yield | -28.43% |
Analyst Forecast
The average price target for Replimune Group is $13.00, which is 10.22% higher than the current price. The consensus rating is "Hold".
| Price Target | $13.00 |
| Price Target Difference | 10.22% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |